Episode Details

Evercore’s Julian Emanuel joins Squawk on the Street with a new contrarian call for the final stretch of the year. Plus, we look ahead to Micron earnings with one analyst who sees the potential for the stock to nearly double—even after a 275% gain this year. And Eli Lilly shares rise after promising mid-stage data for an experimental obesity-drug combination.

 Squawk on the Street Disclaimer

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.